The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2018

Filed:

Apr. 16, 2012
Applicants:

Junho Chung, Seongnam-si, KR;

Sunyoung Park, Seoul, KR;

DO Been Hwang, Seoul, KR;

Hwa Kyoung Lee, Suncheon-si, KR;

Inventors:

Junho Chung, Seongnam-si, KR;

Sunyoung Park, Seoul, KR;

Do Been Hwang, Seoul, KR;

Hwa Kyoung Lee, Suncheon-si, KR;

Assignee:

SNU R&DB FOUNDATION, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); G01N 33/94 (2006.01); B82Y 5/00 (2011.01); A61K 47/48 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); A61K 31/465 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48715 (2013.01); A61K 31/465 (2013.01); A61K 47/48061 (2013.01); A61K 47/48723 (2013.01); B82Y 5/00 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07K 16/2848 (2013.01); C07K 16/44 (2013.01); G01N 33/94 (2013.01); A61K 2039/505 (2013.01); C07K 16/18 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

The present invention relates to a complex in which an anti-cotinine antibody is bound to a conjugate of a binding material and cotinine, and a use of the complex. The complex according to the present invention may be used as an analysis tool in an in vitro biological assay method, and may retain the specific reactivity and the biological function of the binding material, and the capabilities of inducing complement-mediated cell cytotoxicity (CDC) and antibody-dependent cell cytotoxicity (ADCC) and a prolonged in vivo half-life, which are intrinsic characteristics of an antibody.


Find Patent Forward Citations

Loading…